Henan Lingrui Pharmaceutical Co (SHSE:600285) Cash Flow for Dividends: ¥-511 Mil (TTM As of Mar. 2026)


SHSE:600285 Henan Lingrui Pharmaceutical Co Ltd SHSE:600285
97 GF Score
Price ¥22.66
GF Value ¥24.39
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Henan Lingrui Pharmaceutical Co Cash Flow for Dividends?

Henan Lingrui Pharmaceutical Co SHSE:600285 +4.33% 97 Cash Flow for Dividends is ¥-511 Mil as of Mar. 2026. GuruFocus rates SHSE:600285 with a GF Score™ of 97/100 and a GF Value™ of ¥24.39 (Fairly Valued). The stock has 2 warning signs investors should review.

Henan Lingrui Pharmaceutical Co's cash flow for dividends for the three months ended in Mar. 2026 was ¥-0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Mar. 2026 was ¥-511 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Henan Lingrui Pharmaceutical Co's quarterly payment of dividends increased from Sep. 2025 (¥-0 Mil) to Dec. 2025 (¥-1 Mil) but then declined from Dec. 2025 (¥-1 Mil) to Mar. 2026 (¥-0 Mil).

Henan Lingrui Pharmaceutical Co's annual payment of dividends increased from Dec. 2023 (¥-344 Mil) to Dec. 2024 (¥-451 Mil) and increased from Dec. 2024 (¥-451 Mil) to Dec. 2025 (¥-511 Mil).

Henan Lingrui Pharmaceutical Co Cash Flow for Dividends Related Terms

Henan Lingrui Pharmaceutical Co Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Henan Lingrui Pharmaceutical Co's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Henan Lingrui Pharmaceutical Co Cash Flow for Dividends Chart

Henan Lingrui Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only -223.83 -288.84 -344.29 -451.35 -511.29

Henan Lingrui Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.42 -509.57 -0.35 -0.95 -0.05
SHSE:600285
97GF Score
Henan Lingrui Pharmaceutical Co Ltd SHSE:600285
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Henan Lingrui Pharmaceutical Co Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-511 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of ¥-511 Mil mean?
Henan Lingrui Pharmaceutical Co (SHSE:600285) has a Cash Flow for Dividends of ¥-511 Mil as of Mar. 2026. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Henan Lingrui Pharmaceutical Co and its competitors.
Is Henan Lingrui Pharmaceutical Co's Cash Flow for Dividends too high?
Henan Lingrui Pharmaceutical Co's current Cash Flow for Dividends is ¥-511 Mil. Overall, Henan Lingrui Pharmaceutical Co has a GF Score™ of 97/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Henan Lingrui Pharmaceutical Co's Cash Flow for Dividends compare to ZTS and UTHR?
Henan Lingrui Pharmaceutical Co's Cash Flow for Dividends of ¥-511 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Drug Manufacturers company?
A good Cash Flow for Dividends depends on the Drug Manufacturers industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Henan Lingrui Pharmaceutical Co and its competitors. Henan Lingrui Pharmaceutical Co's current Cash Flow for Dividends is ¥-511 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Henan Lingrui Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Henan Lingrui Pharmaceutical Co (SHSE:600285) is currently considered Fairly Valued. The stock's GF Value™ is ¥24.39, compared to a current price of ¥22.66 — trading 7.1% below its estimated fair value. The current Cash Flow for Dividends is ¥-511 Mil. Henan Lingrui Pharmaceutical Co's overall GF Score™ is 97/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Henan Lingrui Pharmaceutical Co (SHSE:600285), the current Cash Flow for Dividends is ¥-511 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Henan Lingrui Pharmaceutical Co (SHSE:600285) Overvalued in 2026?

Based on GuruFocus' analysis, Henan Lingrui Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥22.66 is trading 7.1% below its estimated GF Value™ of ¥24.39. GuruFocus considers Henan Lingrui Pharmaceutical Co to be Fairly Valued.

Key valuation signals for SHSE:600285:

  • Cash Flow for Dividends: ¥-511 Mil
  • GF Value™: ¥24.39 vs. price of ¥22.66 (7.1% below fair value)
  • GF Score™: 97/100 with 2 warning signs

No single metric tells the full story. See the SHSE:600285 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Henan Lingrui Pharmaceutical Co Business Description

Address No. 59 Jiefang Chengguan Road, Xinxian, Xinyang, Henan, CHN, 465550
Henan Lingrui Pharmaceutical Co Ltd is a Chinese company engaged in the development, production, and distribution of pharmaceuticals. The Company's products include tablets, capsules, injections and other medicines.
97GF Score

Get the complete analysis for SHSE:600285

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥22.66
Price
¥24.39
GF Value